![[OncoHost in Labiotech.eu] OncoHost to launch PROphet for non-small cell lung most cancers within the U.S. in 2023](https://blog.ourcrowd.com/wp-content/uploads/2022/12/labiotech.png "[OncoHost in Labiotech.eu] OncoHost to launch PROphet for non-small cell lung most cancers within the U.S. in 2023")
Interview with Ofer Sharon.
Ofer Sharon is the CEO of OncoHost, a biotech firm within the precision oncology area. A doctor by coaching, Sharon has leveraged his expertise in pharma drug growth and entrepreneurship to guide OncoHost by way of the event of PROphet, the corporate’s host response profiling platform, which can launch within the U.S. for non-small cell lung most cancers (NSCLC) sufferers in February 2023.
Learn extra right here.
